|Bid||1.1600 x 800|
|Ask||1.2900 x 4000|
|Day's Range||1.1200 - 1.2600|
|52 Week Range||1.1200 - 9.6300|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for LHDX
The company hopes to hear back from the FDA before flu season begins on whether it can market its at-home combined Covid-flu test under an emergency use authorization.
Lucira CEO Erik Engelson joins Yahoo Finance Live to discuss company earnings and the future of at-home COVID-19 and flu testing.
Earlier today, Lucira Health released financial results for the second quarter ended June 30, 2022. Joining me on today's call are Erik Engelson, president and chief executive officer; and Dan George, chief financial officer.